Cartesian Therapeutics (RNAC) Return on Capital Employed Growth (5y) (2021 - 2026)
Cartesian Therapeutics (RNAC) Return on Capital Employed Growth (5y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cartesian Therapeutics |
261.84 Mn |
261.84 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-133.00 |
| Dec 31, 2025 |
1,712.00 |
| Sep 30, 2025 |
9,541.00 |
| Jun 30, 2025 |
7,735.00 |
| Mar 31, 2025 |
7,980.00 |
| Dec 31, 2024 |
14,115.00 |
| Sep 30, 2024 |
38,094.00 |
| Jun 30, 2024 |
24,086.00 |
| Mar 31, 2024 |
26,959.00 |
| Dec 31, 2023 |
31,383.00 |
| Sep 30, 2023 |
15,948.00 |
| Jun 30, 2023 |
6,003.00 |
| Mar 31, 2023 |
6,654.00 |
| Dec 31, 2022 |
7,743.00 |
| Sep 30, 2022 |
7,420.00 |
| Jun 30, 2022 |
8,904.00 |
| Mar 31, 2022 |
7,401.00 |
| Dec 31, 2021 |
4,192.00 |
| Sep 30, 2021 |
1,334.00 |
